Virtu Financial LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1533964 New York, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,368,893

+$350,858 QoQ

Shares Held

10,835

-27.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#954

of 2,265 holders

Holding Since

Sep 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Virtu Financial LLC holds $14,372,542 across 6 Drug Manufacturers - General names. GILD ranks #4 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	5,787	$6,941,101
2	NVS	Novartis AG	17,757	$2,782,877
3	PFE	Pfizer Inc	97,068	$2,337,397
4	GILD	Gilead Sciences, Inc. This page	10,835	$1,368,893
5	SNY	Sanofi	22,088	$942,274
6	SCLX	Scilex Holding Co	34,797	$0

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,368,893	10,835	-27.0%	Shares	Defined	2026-08-13
2024-06-30	$1,018,035	14,838	-76.5%	Shares	Defined	2024-08-09
2024-03-31	$4,633,135	63,251	+664.5%	Shares	Defined	2024-05-20
2022-12-31	$710,322	8,274	+87.4%	Shares	Defined	2023-02-15
2022-09-30	$272,299	4,414	-85.8%	Shares	Defined	2022-11-07
2022-03-31	$1,853,948	31,185	+190.3%	Shares	Defined	2022-05-17
2020-09-30	$678,723	10,741	—	Shares	Defined	2020-12-11
No filing history on record for this holder in this stock.